FasT Biopharma
Manufacturing · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
10 Aston Park, Aston Rowant, Oxfordshire...Website
www.fastbiopharma.comRevenue
<$5 MillionIndustry
About FasT Biopharma
FasT Biopharma Org Chart
Is FasT Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
FasT Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at FasT Biopharma
Funding: Get notified immidiatlly once FasT Biopharma has new funding data
Check if FasT Biopharma has recently received funding, and reach out quickly before it becomes old news!
Check out if FasT Biopharma is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if FasT Biopharma had a recent Job posting/layoffs
Earning: See what the market has to say on FasT Biopharma recently announced quarterly report
Product Launch: Get notified when FasT Biopharma launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at FasT Biopharma
Find more new buyers
Compare Similar Companies to FasT Biopharma
Compare insights from companies similar to FasT Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
FasT Biopharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
FasT Biopharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about FasT Biopharma.
FasT Biopharma Tech Stack
A closer look at the technologies used by FasT Biopharma
Top Manufacturing Companies
Frequently Asked Questions Regarding FasT Biopharma
FasT Biopharma specializes in developing breakthrough therapies aimed at preventing cell death, a critical factor in various diseases. Their candidate therapeutics focus on blocking the Fas ligand (FasL) pathway, which is linked to conditions such as blindness, cancer immune failure, diabetes, and viral pathologies. The company targets a wide range... Read More